Literature DB >> 27655307

Knowledge and pharmacological management of Alzheimer's disease by managing community pharmacists: a nationwide study.

Natalie Zerafa1, Charles Scerri2.   

Abstract

Background Managing community pharmacists can play a leading role in supporting community dwelling individuals with Alzheimer's disease and their caregivers. Objective The main purpose of this study was to assess knowledge of managing community pharmacists towards Alzheimer's disease and its pharmacological management. Setting Community pharmacies in the Maltese islands. Method A nationwide survey was conducted with full-time managing community pharmacists in possession of a tertiary education degree in pharmacy studies. The level of knowledge was investigated using the Alzheimer's Disease Knowledge Scale and the Alzheimer's Disease Pharmacotherapy Measure. Participants were also asked to rate a number of statements related to disease management. Results Maltese managing community pharmacists (57 % response rate) had inadequate knowledge on risk factors, caregiving issues and pharmacological management of Alzheimer's disease. Age and number of years working in a community pharmacy setting were found to be negatively correlated with increased knowledge. Conclusion The findings highlight the need of providing training and continued educational support to managing community pharmacists in order to provide quality advice to individuals with dementia and their caregivers in the community.

Entities:  

Keywords:  Alzheimer’s disease; Dementia; Knowledge; Malta; Maltese islands; Managing community pharmacist; Pharmacotherapy

Mesh:

Year:  2016        PMID: 27655307     DOI: 10.1007/s11096-016-0380-8

Source DB:  PubMed          Journal:  Int J Clin Pharm


  20 in total

1.  Knowledge about Alzheimer's disease among Norwegian psychologists: the Alzheimer's disease knowledge scale.

Authors:  Inger Hilde Nordhus; Børge Sivertsen; Ståle Pallesen
Journal:  Aging Ment Health       Date:  2011-11-30       Impact factor: 3.658

2.  Basics of Alzheimer's disease prevention.

Authors:  Jack C de la Torre
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 3.  Behavioral effects of current Alzheimer's disease treatments: a descriptive review.

Authors:  Jeffrey L Cummings; Joan Mackell; Daniel Kaufer
Journal:  Alzheimers Dement       Date:  2008-01       Impact factor: 21.566

4.  Pharmacologic management by clinical pharmacists of behavioral and psychological symptoms of dementia in nursing home residents: results from a pilot study.

Authors:  Carlos H Rojas-Fernandez; Marty Eng; Nicole D Allie
Journal:  Pharmacotherapy       Date:  2003-02       Impact factor: 4.705

5.  The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes.

Authors:  I Schmidt; C B Claesson; B Westerholm; L G Nilsson; B L Svarstad
Journal:  J Am Geriatr Soc       Date:  1998-01       Impact factor: 5.562

6.  Patient safety problem identification and solution sharing among rural community pharmacists.

Authors:  Kimberly A Galt; Kevin T Fuji; Jennifer Faber
Journal:  J Am Pharm Assoc (2003)       Date:  2013 Nov-Dec

7.  An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project.

Authors:  Juanita Westbury; Shane Jackson; Peter Gee; Gregory Peterson
Journal:  Int Psychogeriatr       Date:  2009-10-09       Impact factor: 3.878

8.  The Alzheimer's Disease Knowledge Scale: development and psychometric properties.

Authors:  Brian D Carpenter; Steve Balsis; Poorni G Otilingam; Priya K Hanson; Margaret Gatz
Journal:  Gerontologist       Date:  2009-03-25

9.  Cognitive memory screening and referral program in community pharmacies in the United States.

Authors:  Nathaniel M Rickles; Jann B Skelton; Jennifer Davis; Jennifer Hopson
Journal:  Int J Clin Pharm       Date:  2013-12-20

10.  Behavioral and psychological symptoms of dementia.

Authors:  J Cerejeira; L Lagarto; E B Mukaetova-Ladinska
Journal:  Front Neurol       Date:  2012-05-07       Impact factor: 4.003

View more
  3 in total

1.  A Comparison of the Knowledge of Alzheimer's Disease among Community Pharmacists Based on Regional Practice Setting Using the Alzheimer's Disease Knowledge Scale (ADKS).

Authors:  Jenna Stearns; Rachel Burgoon; Zachary Sahadak; Beka Alazar; Marty L Eng
Journal:  Innov Pharm       Date:  2021-06-10

2.  Knowledge on Alzheimer's Disease among Public Hospitals and Health Clinics Pharmacists in the State of Selangor, Malaysia.

Authors:  Thimarul Huda Mat Nuri; Yet Hoi Hong; Long Chiau Ming; Suhaidah Mohd Joffry; Muhamad Faiz Othman; Chin Fen Neoh
Journal:  Front Pharmacol       Date:  2017-10-26       Impact factor: 5.810

3.  Community Pharmacists' Knowledge Regarding Donepezil Averse Effects and Self-Care Recommendations for Insomnia for Persons with AD.

Authors:  Marketa Marvanova; Paul Jacob Henkel
Journal:  Pharmacy (Basel)       Date:  2017-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.